Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 5 | 5 |
| List of Tables | 7 | 1 |
| List of Figures | 8 | 2 |
| Introduction | 10 | 1 |
| Emerging Pharmaceutical Market: South Africa Industry Characteristics | 11 | 26 |
| Pharmaceutical Market Size and Growth in South Africa | 11 | 1 |
| Environmental Disease Burden | 12 | 3 |
| HIV/AIDS | 15 | 2 |
| Tuberculosis | 17 | 1 |
| Patented and Generic Drugs Market Share | 18 | 2 |
| Imports and Exports | 20 | 1 |
| Imports | 20 | 1 |
| Exports | 21 | 1 |
| Balance of Trade | 22 | 1 |
| Key Domestic Players in South Africa | 23 | 1 |
| Aspen Pharmacare | 23 | 1 |
| Overview | 23 | 1 |
| SWOT Analysis | 23 | 1 |
| Adcock Ingram | 24 | 1 |
| Overview | 24 | 1 |
| SWOT Analysis | 24 | 1 |
| Cipla Medpro | 25 | 1 |
| Overview | 25 | 1 |
| SWOT Analysis | 25 | 1 |
| Key Foreign Players in South Africa | 26 | 1 |
| Sanofi | 26 | 1 |
| Overview | 26 | 1 |
| SWOT Analysis | 26 | 1 |
| Pfizer | 27 | 1 |
| Overview | 27 | 1 |
| SWOT Analysis | 27 | 1 |
| Roche | 28 | 1 |
| Overview | 28 | 1 |
| SWOT Analysis | 28 | 1 |
| Ranbaxy | 29 | 1 |
| Overview | 29 | 1 |
| SWOT Analysis | 29 | 1 |
| GlaxoSmithKline | 30 | 1 |
| Overview | 30 | 1 |
| SWOT Analysis | 30 | 1 |
| Merck &Co | 31 | 1 |
| Overview | 31 | 1 |
| SWOT Analysis | 31 | 1 |
| Novartis | 32 | 1 |
| Overview | 32 | 1 |
| SWOT Analysis | 32 | 1 |
| Market Drivers and Restraints | 33 | 1 |
| Drivers | 33 | 1 |
| Well-established and High-quality Infrastructure | 33 | 1 |
| Growth in Contract Research Organization Industry Fuelled by a Number of Factors | 33 | 1 |
| Establishing the Generics Industry | 33 | 1 |
| Better Regulatory Framework due to Introduction of South African Health Products Regulatory Authority | 34 | 1 |
| Restraints | 34 | 1 |
| Slow Drug Approval Process Increases the Time it Takes Drugs Reach Patients | 35 | 1 |
| Counterfeit Market to Limit the Investments of Foreign Players in the Domestic Market | 35 | 1 |
| Government Healthcare Reform Plans Aimed at Cutting Drug Expenditure | 35 | 1 |
| Inadequate Funds Available for Public Healthcare System | 35 | 1 |
| PESTLE Analysis | 36 | 1 |
| Emerging Pharmaceutical Market: South Africa Macroeconomic Environment | 37 | 15 |
| Demographic Analysis | 37 | 1 |
| Introduction | 37 | 1 |
| Population Size, Growth and Structure | 38 | 1 |
| Changes in Life Expectancy at Birth | 39 | 1 |
| Infant Mortality Rate | 40 | 1 |
| Rural/Urban Distribution | 41 | 1 |
| Population by Gender | 42 | 1 |
| Gross Domestic Product | 42 | 1 |
| Healthcare Expenditure | 43 | 3 |
| Healthcare System | 46 | 1 |
| Health Workforce and Infrastructure in South Africa | 46 | 1 |
| Physicians | 46 | 2 |
| Nursing and Midwifery Personnel | 48 | 1 |
| Dentistry Personnel | 49 | 1 |
| Pharmaceutical Personnel | 50 | 1 |
| Hospital Infrastructure | 51 | 1 |
| Emerging Pharmaceutical Market: South Africa Healthcare Regulation | 52 | 5 |
| Pharmaceutical Regulation in South Africa | 52 | 1 |
| Intellectual Property Rights | 53 | 1 |
| Health Insurance Coverage | 53 | 1 |
| Pricing and Reimbursement | 54 | 1 |
| Pricing | 54 | 1 |
| Reimbursement | 55 | 1 |
| Clinical Trials | 55 | 2 |
| Emerging Pharmaceutical Market: South Africa Industry Trends | 57 | 7 |
| Strategic Consolidations | 57 | 2 |
| Mergers and Acquisitions | 59 | 1 |
| Deals by Year | 59 | 1 |
| Deals by Type | 60 | 1 |
| Deals by Value | 61 | 1 |
| Top M&A Deals | 62 | 1 |
| Nycomed Acquires Nycomed Madaus | 62 | 1 |
| Adcock Ingram Acquires Donmed Pharmaceuticals | 62 | 1 |
| Cadila Healthcare Acquires Simayla Pharmaceuticals | 62 | 1 |
| Enaleni Pharmaceuticals Acquires Bioharmony | 63 | 1 |
| Paladin Labs Acquires 35% Stake in Pharmaplan | 63 | 1 |
| Licensing Agreements | 63 | 1 |
| Top Licensing Deals | 63 | 1 |
| Recordati Enters into a Licensing Agreement with Pharmaplan | 63 | 1 |
| Emerging Pharmaceutical Market: South Africa Contract Research Organization Industry | 64 | 8 |
| Contract Research Organizations | 64 | 1 |
| Key International Contract Research Organization Players in South Africa | 64 | 1 |
| Quintiles | 64 | 1 |
| Business Description | 65 | 1 |
| Pharmaceutical Product Development | 65 | 1 |
| Business Description | 65 | 1 |
| Inc Research | 66 | 1 |
| Business Description | 66 | 1 |
| Parexel | 67 | 1 |
| Business Description | 67 | 1 |
| Icon plc. | 68 | 1 |
| Business Description | 68 | 1 |
| PRA International | 69 | 1 |
| Business Description | 69 | 1 |
| Key Domestic Contract Research Organization Players in South Africa | 70 | 1 |
| African Clinical Research Organization | 70 | 1 |
| Business Description | 70 | 1 |
| OnQ | 71 | 1 |
| Business Description | 71 | 1 |
| Emerging Pharmaceutical Market: South Africa - Appendix | 72 | 3 |
| Market Definitions | 72 | 1 |
| Abbreviations | 72 | 1 |
| Sources | 73 | 1 |
| Research Methodology | 73 | 2 |
| Industry Performance | 73 | 1 |
| Macroeconomic Environment | 73 | 1 |
| Healthcare Regulations | 74 | 1 |
| Industry Trends | 74 | 1 |
| Contact Us | 74 | 1 |
| Disclaimer | 74 | 1 |